BLUMY yields 5.04% · JNJ yields 2.13%● Live data
📍 BLUMY pulled ahead of the other in Year 1
Combined, BLUMY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLUMY + JNJ for your $10,000?
Blue Moon Group Holdings Limited engages in the research, design, development, manufacture, and sale of personal hygiene, home care, and fabric care products in China. It offers fabric care products, including machine wash laundry, pre-wash treatment, underwear laundry, hand wash, strain removers, and fabric softeners, as well as baby liquid laundry detergents; personal hygiene products comprising liquid soaps; toilet and bathroom cleaners; and general home care products, such as anti-mould cleansers, washing machine cleaners, floor cleaners, bleaches, glass cleaners, multi-surface cleaners, and rust cleaners; and antiseptic disinfectant liquids. The company also provides kitchen cleaning products, including utensil, fruit, and vegetable cleaning products, as well as range of hood cleaners. The company offers its products under the Blue Moon, Supreme, Jingxiang, and Tianlu brands. It sells its products through e-commerce platforms, online stores, hypermarkets, supermarkets, and offline distributors. The company was founded in 1992 and is headquartered in Guangzhou, China.
Full BLUMY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.